Subcutaneous Administration of Otelixizumab is Limited by Injection Site Reactions: Results of an Exploratory Study in Type 1 Diabetes Mellitus Patients

2016 ◽  
Vol 124 (05) ◽  
pp. 288-293 ◽  
Author(s):  
A. MacDonald ◽  
P. Ambery ◽  
J. Donaldson ◽  
K. Hicks ◽  
B. Keymeulen ◽  
...  
CMAJ Open ◽  
2019 ◽  
Vol 7 (2) ◽  
pp. E246-E251 ◽  
Author(s):  
B. Cord Lethebe ◽  
Tyler Williamson ◽  
Stephanie Garies ◽  
Kerry McBrien ◽  
Charles Leduc ◽  
...  

2013 ◽  
Author(s):  
Blake M. Lancaster ◽  
Ashley M. Lugo ◽  
Lynne Clure ◽  
Kate S. Holman ◽  
Ryan T. Thorson

Sign in / Sign up

Export Citation Format

Share Document